These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2365493)

  • 1. Human multi-drug-resistant cancer cells exhibit a high degree of selectivity for stereoisomers of verapamil and quinidine.
    Eliason JF; Ramuz H; Kaufmann F
    Int J Cancer; 1990 Jul; 46(1):113-7. PubMed ID: 2365493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R; Nygren P
    Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro.
    Eliason JF; Ramuz H; Yoshikubo T; Ishikawa T; Yamamoto T; Tsuruo T
    Biochem Pharmacol; 1995 Jul; 50(2):187-96. PubMed ID: 7632162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft.
    Plumb JA; Wishart GC; Setanoians A; Morrison JG; Hamilton T; Bicknell SR; Kaye SB
    Biochem Pharmacol; 1994 Jan; 47(2):257-66. PubMed ID: 8304970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells.
    Marks DC; Belov L; Davey MW; Davey RA; Kidman AD
    Leuk Res; 1992 Dec; 16(12):1165-73. PubMed ID: 1361210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of verapamil on a multi-drug resistant bladder carcinoma cell line and its potential as an intravesical chemotherapeutic agent.
    Long JP; Prout GR; Wong YK; Lin CW
    J Urol; 1990 May; 143(5):1053-6. PubMed ID: 2329596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil.
    Pirker R; Keilhauer G; Raschack M; Lechner C; Ludwig H
    Int J Cancer; 1990 May; 45(5):916-9. PubMed ID: 2335394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity.
    Vellonen KS; Honkakoski P; Urtti A
    Eur J Pharm Sci; 2004 Oct; 23(2):181-8. PubMed ID: 15451006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
    Lee SY; Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Jung MH; Kim SH; Lee EO; Ahn KS; Ahn KS; Kim SH
    Environ Toxicol; 2011 Aug; 26(4):424-31. PubMed ID: 20196146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles.
    Song XR; Cai Z; Zheng Y; He G; Cui FY; Gong DQ; Hou SX; Xiong SJ; Lei XJ; Wei YQ
    Eur J Pharm Sci; 2009 Jun; 37(3-4):300-5. PubMed ID: 19491019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines.
    Warr JR; Brewer F; Anderson M; Fergusson J
    Cell Biol Int Rep; 1986 May; 10(5):389-99. PubMed ID: 3719706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer.
    Xu JM; Song ST; Tang ZM; Liu XQ; Jiang ZF; Zhou L; Li YB; Huang Y
    Breast Cancer Res Treat; 1998 Jun; 49(3):251-9. PubMed ID: 9776509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells.
    Malik IA; Costea NV
    Hematol Oncol; 1992; 10(3-4):225-31. PubMed ID: 1398518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antiarrhythmic activity of the polymeric forms of quinidine, trimecaine, etatsizin, propranolol and verapamil].
    Sidorenko GI; Gurin AV; Koliadko MG; Iurkshtovich TL; Nedorezov VL
    Eksp Klin Farmakol; 1993; 56(3):27-30. PubMed ID: 8219985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.